<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.2662  Xylazine.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains xylazine hydrochloride equivalent to:</p><p class="depth2"><em>(1)</em> 20 milligrams (mg) xylazine.</p><p class="depth2"><em>(2)</em> 100 mg xylazine.</p><p class="depth2"><em>(3)</em> 300 mg xylazine.</p><p class="depth1"><em>(b)</em> Sponsors. See sponsors in Sec. 510.600(c) of this chapter for uses as in paragraph (d) of this section.</p><p class="depth2"><em>(1)</em> No. 054628 for use of product described in paragraph (a)(2) of this section as in paragraph (d)(2) of this section.</p><p class="depth2"><em>(2)</em> Nos. 000010 and 061623 for use of product described in paragraph (a)(2) of this section as in paragraphs (d)(2), (d)(3)(i), (d)(3)(ii)(A), and (d)(3)(iii) of this section.</p><p class="depth2"><em>(3)</em> Nos. 000859 and 061651 for use of product described in paragraph (a)(1) of this section as in paragraph (d)(1); and product described in paragraph (a)(2) of this section as in paragraphs (d)(2), (d)(3)(i), (d)(3)(ii)(A), and (d)(3)(iii) of this section.</p><p class="depth2"><em>(4)</em> No. 059399 for use of product described in paragraph (a)(1) of this section as in paragraph (d)(1) of this section; product described in paragraph (a)(2) of this section as in paragraphs (d)(2), (d)(3)(i), (d)(3)(ii)(A), and (d)(3)(iii) of this section; and product described in paragraph (a)(3) of this section as in paragraphs (d)(3)(i), (d)(3)(ii)(B), and (d)(3)(iii) of this section.</p><p class="depth1"><em>(c)</em> Special considerations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth1"><em>(d)</em> Conditions of use--(1) Dogs and cats--(i) Amount. 0.5 mg/pound (lb) intravenously or 1.0 mg/lb subcutaneously.</p><p class="depth2"><em>(1)</em> Dogs and cats--(i) Amount. 0.5 mg/pound (lb) intravenously or 1.0 mg/lb subcutaneously.</p><p class="depth3"><em>(i)</em> Amount. 0.5 mg/pound (lb) intravenously or 1.0 mg/lb subcutaneously.</p><p class="depth3"><em>(ii)</em> Indications for use. To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia.</p><p class="depth2"><em>(2)</em> Horses--(i) Amount. 0.5 mg/lb intravenously or 1.0 mg/lb intramuscularly.</p><p class="depth3"><em>(i)</em> Amount. 0.5 mg/lb intravenously or 1.0 mg/lb intramuscularly.</p><p class="depth3"><em>(ii)</em> Indications for use. To produce sedation, as an analgesic, and as a preanesthetic to local or general anesthesia.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses intended for human consumption.</p><p class="depth2"><em>(3)</em> Elk and deer--(i) Amount. Administer intramuscularly, by hand syringe, or by syringe dart, in the heavy muscles of the croup or shoulder as follows:</p><p class="depth3"><em>(i)</em> Amount. Administer intramuscularly, by hand syringe, or by syringe dart, in the heavy muscles of the croup or shoulder as follows:</p><p class="depth4"><em>(A)</em> Elk (Cervus canadensis): 0.25 to 0.5 mg/lb.</p><p class="depth4"><em>(B)</em> Mule deer (Odocoileus hemionus), sika deer (Cervus nippon), and white-tailed deer (Odocoileus virginianus): 1 to 2 mg/lb.</p><p class="depth4"><em>(C)</em> Fallow deer (Dama dama): 2 to 4 mg/lb.</p><p class="depth3"><em>(ii)</em> Indications for use. (A) To produce sedation, as an analgesic, and as a preanesthetic to local anesthesia.</p><p class="depth4"><em>(A)</em> To produce sedation, as an analgesic, and as a preanesthetic to local anesthesia.</p><p class="depth4"><em>(B)</em> To produce sedation, accompanied by a shorter period of analgesia. May be used to calm and facilitate handling of fractious animals for diagnostic procedures, for minor surgical procedures, for therapeutic medication for sedation and relief of pain following injury or surgery, and as a preanesthetic to local anesthetic. At the recommended dosages, can be used in conjunction with local anesthetics, such as procaine or lidocaine.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in domestic food-producing animals. Do not use in Cervidae less than 15 days before or during the hunting season.
[68 FR 26206, May 15, 2003, as amended at 75 FR 10167, Mar. 5, 2010, 78 FR 21060, Apr. 9, 2013; 79 FR 16198, Mar. 25, 2014; 79 FR 21127, Apr. 15, 2014; 79 FR 74020, Dec. 15, 2014; 80 FR 13230, Mar. 13, 2015]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
